Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer.
Awad MM, Forde PM, Girard N, Spicer J, Wang C, Lu S, Mitsudomi T, Felip E, Broderick SR, Swanson SJ, Brahmer J, Kerr K, Saylors GB, Chen KN, Gharpure V, Neely J, Balli D, Hu N, Provencio Pulla M.
Awad MM, et al. Among authors: lu s.
J Clin Oncol. 2025 Jan 8:JCO2402239. doi: 10.1200/JCO-24-02239. Online ahead of print.
J Clin Oncol. 2025.
PMID: 39778121